resveratrol has been researched along with Scleroderma, Systemic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheriet, T; Eid, AH; Giordo, R; Pintus, G; Posadino, AM; Ramli, I; Zayed, H | 1 |
| Chen, W; Chen, Y; Huang, M; Liang, J; Lin, B; Lin, Q; Wu, Q; Xing, Y; Xu, X; Yao, Q | 1 |
| Chu, H; Jiang, S; Liu, L; Liu, Q; Qiu, J; Wan, W; Wang, J; Xue, Y; Zheng, S; Zhu, X; Zou, H | 1 |
| Chu, H; Fang, F; Ghosh, AK; Hinchcliff, ME; Marangoni, RG; Varga, J; Wang, J; Wei, J | 1 |
| Alberto, P; Cerinic, MM; Falcini, F; Fernanda, F; Gabriele, S; Generini, S; Marco, MC; Pignone, A; Sergio, G; Simonini, G | 1 |
2 review(s) available for resveratrol and Scleroderma, Systemic
| Article | Year |
|---|---|
Potential Therapeutic Targets of Resveratrol in the Prevention and Treatment of Pulmonary Fibrosis.
Topics: Arthritis, Rheumatoid; Humans; Lung Diseases, Interstitial; Pulmonary Fibrosis; Resveratrol; Scleroderma, Systemic | 2023 |
Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis.
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Endothelium, Vascular; Humans; In Vitro Techniques; Melatonin; Nitric Oxide; Oxidative Stress; Pregnatrienes; Probucol; Raynaud Disease; Reactive Oxygen Species; Reperfusion Injury; Resveratrol; Scleroderma, Systemic; Selenium; Stilbenes; Vitamin E | 2000 |
3 other study(ies) available for resveratrol and Scleroderma, Systemic
| Article | Year |
|---|---|
Resveratrol Ameliorates Systemic Sclerosis via Suppression of Fibrosis and Inflammation Through Activation of SIRT1/mTOR Signaling.
Topics: Bleomycin; Cells, Cultured; Fibrosis; Humans; Inflammation; Resveratrol; Scleroderma, Systemic; Signal Transduction; Sirtuin 1; TOR Serine-Threonine Kinases | 2020 |
Sirt1 ameliorates systemic sclerosis by targeting the mTOR pathway.
Topics: Animals; Biopsy; Bleomycin; Cells, Cultured; Collagen; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Fibroblasts; Gene Knockdown Techniques; Humans; Immunohistochemistry; Mice; Mice, Inbred C3H; Phosphorylation; Real-Time Polymerase Chain Reaction; Resveratrol; RNA, Messenger; Scleroderma, Systemic; Signal Transduction; Sirolimus; Sirtuin 1; Skin; Stilbenes; TOR Serine-Threonine Kinases; Tumor Necrosis Factor-alpha | 2017 |
The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling.
Topics: Animals; Case-Control Studies; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Fibroblasts; Humans; Mice; p300-CBP Transcription Factors; Platelet-Derived Growth Factor; Real-Time Polymerase Chain Reaction; Resveratrol; RNA, Messenger; Scleroderma, Systemic; Signal Transduction; Sirtuin 1; Skin; Smad Proteins; Stilbenes; Transforming Growth Factor beta | 2015 |